A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States)

Cancer Causes and Control

Volumn 7, Issue 3, 1996, Pages 382-390

  Cook, Linda S ^a,b   White, Emily ^a,b   Schwartz, Stephen M ^a,b   McKnight, Barbara ^a,b   Daling, Janet R ^a,b   Weiss, Noel S ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Breast neoplasms; Menopausal status; Second primary neoplasms; United States; Women

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTRALATERAL BREAST; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FORECASTING; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; ODDS RATIO; OVARIECTOMY; PARITY; POPULATION SURVEILLANCE; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS; WASHINGTON;

EID: 0029946183     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00052945     Document Type: Article

References (36)

1. Schottenfeld D, Berg J. Incidence of multiple primary cancers. IV. Cancer of the female breast and genital organs. JNCI 1971; 46: 161-70.
2. Murakami R, Hiyama T, Hanai A, Fujimoto I. Second primary cancers following female breast cancer in Osaka, Japan - a population-based cohort study. Jpn J Clin Oncol 1987; 17: 293-302.
3. Hislop TG, Elwood JM, Coldman AJ, et al. Second primary cancers of the breast: incidence and risk factors. Br J Cancer 1984; 49: 79-85.
4. Robbins GF, Berg JW. Bilateral primary breast cancers: A prospective clinicopathological study. Cancer 1964; 17: 1501-27.
5. Fisher ER, Fisher B, Sass R, Wickerham L, Collaborating NSABP Investigators. Pathological findings from the national surgical adjuvant breast project (protocol no. 4). Cancer 1984; 54: 3002-11.
6. Chaudary MA, Millis RR, Bulbrook RD, Hayward JL. Family history and bilateral primary breast cancer. Breast Cancer Res Trtmt 1985; 5: 201-5.
7. Bernstein JL, Thompson WD, Risch N, Holford TR. The genetic epidemiology of second primary breast cancer. Am J Epidemiol 1992; 136: 937-48.
8. Kato I, Miura S, Yoshida M, Tominaga S. Risk factors of multiple primary cancers in breast cancer patients. Jpn J Cancer Res 1986; 77: 296-304.
9. Horn P, Thompson WD. Risk of contralateral breast cancer: associations with factors related to initial breast cancer. Am J Epidemiol 1988; 128: 309-23.
10. Boice JD Jr, Harvey EB, Blettner M, et al. Cancer in the contralateral breast after radiotherapy for breast cancer. New Eng J Med 1992; 326: 781-5.
11. Bernstein JL, Thompson WD, Risch N, Holford TR. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 1992; 136: 925-36.
12. Horn PL, Thompson WD. Risk of contralateral breast cancer: associations with histologic, clinical, and therapeutic factors. Cancer 1988; 62: 412-24.
13. Horn PL, Thompson WD, Schwartz SM. Factors associated with the risk of second primary breast cancer: an analysis of data from the Connecticut tumor registry. J Chron Dis 1987; 40: 1003-11.
14. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cyctotoxic, or immune therapy. Lancet 1992; 339: 1-15.
15. Horn PL, Thompson WD. Exposure to chemotherapeutic agents and the risk of a second breast cancer: preliminary findings. Yale J Biol Med 1988; 61: 223-31.
16. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cyctotoxic, or immune therapy. Lancet 1992; 339: 71-85.
17. Arriagada R, Rutqvist LE. Adjuvant chemotherapy in early breast cancer and incidence of new primary malignancies. Lancet 1991; 338: 535-8.
18. Cook LS, Weiss NS, Schwartz SM, et al. A population-based study of tamoxifen therapy for breast cancer and subsequent ovarian, endometrial, and breast cancer. JNCI 1995; 87: 1359-64.
19. Daling JR, Malone KE, Voigt LF, et al. Risk of breast cancer among young women: relationship to induced abortion. JNCI 1994; 86: 1584-92.
20. Stanford JL, Weiss NS, Voigt LF, et al. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA, in press.
21. The Centers for Disease Control. Long-term oral contraceptive use and the risk of breast cancer. JAMA 1983; 249: 1591-5.
22. Armstrong BK, White E, Saracci R. Principles of Exposure Measurement in Epidemiology. New York, NY (USA): Oxford University Press, 1992; Monogr Epi Biostat. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol I. The Analysis of Case-control Studies. Lyon, France: International Agency for Research on Cancer, 1980; IARC Sci. Pub. No. 32.
23. Armstrong BK, White E, Saracci R. Principles of Exposure Measurement in Epidemiology. New York, NY (USA): Oxford University Press, 1992; Monogr Epi Biostat. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol I. The Analysis of Case-control Studies. Lyon, France: International Agency for Research on Cancer, 1980; IARC Sci. Pub. No. 32.
24. Armstrong BK, White E, Saracci R. Principles of Exposure Measurement in Epidemiology. New York, NY (USA): Oxford University Press, 1992; Monogr Epi Biostat. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol I. The Analysis of Case-control Studies. Lyon, France: International Agency for Research on Cancer, 1980; IARC Sci. Pub. No. 32.
25. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research. Principles and Quantitative Methods. New York, NY (USA): Van Nostrand Reinhold, 1982.
26. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15: 36-47.
27. Horn-Ross PL. Multiple primary cancers involving the breast. Epidemiol Rev 1993; 15: 169-75.
28. Storm HH, Andersson M, Boice JD Jr, et al. Adjuvant radiotherapy and risk of contralateral breast cancer. JNCI 1992; 84: 1245-50.
29. Burns PE, Dabbs K, May C, et al. Bilateral breast cancer in northern Alberta: risk factors and survival patterns. Can Med Assoc J 1984; 130: 881-6.
30. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993; 15: 110-32.
31. Lindblom A. Familial breast cancer and genes involved in breast carcinogenesis. Breast Cancer Res Trtmt 1995; 34: 171-83.
32. Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk. JAMA 1993; 270: 1563-8.
33. Kelsey JL. Breast cancer epidemiology: summary and future directions. Epidemiol Rev 1993; 15: 256-63.
34. Dixon JM, Anderson TJ, Page DL, et al. Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br J Surg 1983; 70: 513-6.
35. Hankey BF, Curtis RE, Naughton MD, et al. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. JNCI 1983; 70: 797-804.
36. Frass BA, Roberson PL, Lichter AS. Dose to the contralateral breast due to primary breast irradiation. Int J Rad Oncol Biol Phys 1985; 11: 485-97.